Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;11(2):135-46.
doi: 10.2174/156800911794328493.

Advances in nano drugs for cancer chemotherapy

Affiliations
Review

Advances in nano drugs for cancer chemotherapy

Imran Ali et al. Curr Cancer Drug Targets. 2011 Feb.

Abstract

In spite of some medications, millions of peoples are dying every year due to cancer. Additionally, the survival patients suffer from various serious side effects due to the use of available anti-neoplastic medicines. The development of nanoparticles based drugs is seems to be effective providing low side effects and targeted action on cancer cells. The present article describes the state-of-art of nano drugs in cancer chemotherapy. The nano drugs are targeted selective and specific towards tumors only resulting into better treatment. The important molecules used for preparation nano drugs are cisplatin, carboplatin, bleomycin, 5-fluorouracil, doxorubicin, dactinomycin, 6-mercaptopurine, paclitaxel, topotecan, vinblastin and etoposide etc. The most commonly used materials for preparing nanoparticles carriers are dendrimers, polymer, liposome, micelles, inorganic, organic nanoparticles etc. A survey was carried out on the drugs available in the market and given in tabular form. However, the commonly used nano drugs till date are liposome dendrimer and some other materials based nanoparticles. Attempts have been made to explain mechanism of action of nano drugs. The future perspectives have also been highlighted in to the conclusion part.

PubMed Disclaimer

MeSH terms

LinkOut - more resources